About Hospital de Mar
El Hospital del Mar, es un centro sanitario general moderno, universitario, activo, investigador, que atiende patologías de complejidad media y alta situado en el Paseo Marítimo de Barcelona. Fue inaugurado en el año 1905, siendo uno de los hospitales más importantes de Barcelona.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital de Mar
During the past decade, Hospital de Mar conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital de Mar" #1 sponsor was "Merck Sharp & Dohme LLC" with 3 trials, followed by "AB Biotics, SA" with 1 trials
sponsored, "Grupo Español de Tratamiento de Tumores de Cabeza y Cuello" with 1 trials sponsored, "Grupo Español de Tumores Huérfanos e Infrecuentes" with 1 trials sponsored and "LifeCell"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Mar"
#1 collaborator was "Apices Soluciones S.L." with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Global Research Solutions" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE" with 1 trials as a collaborator and "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hospital de Mar
According to Clinical.Site data, the most researched conditions in "Hospital de Mar" are
"Prostatic Neoplasms" (3 trials), "Complicated Intra-Abdominal Infections, cIAIs" (1 trials), "Degenerative Lesion of Articular Cartilage of Knee" (1 trials), "Depressive Disorder, Major" (1 trials) and "Hernia" (1 trials). Many other conditions were trialed in "Hospital de Mar" in a lesser frequency.
Clinical Trials Intervention Types at Hospital de Mar
Most popular intervention types in "Hospital de Mar" are "Drug" (7 trials), "Biological" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (3 trials), "Enzalutamide" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "ATM-AVI" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital de Mar
The vast majority of trials in "Hospital de Mar" are
5 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital de Mar
Currently, there are NaN active trials in "Hospital de Mar".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital de Mar,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Mar, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".